Information Density: Keytruda – Signal Evidence & AI Readability

Keytruda

(https://keytruda.com) 📸 Data Snapshot: May 31, 2026
Information Density — The Lens

Classify each sentence as substantive or hollow. Grounding markers — numbers, currencies, dates, technical units, named entities — outweigh marketing adjectives. When fluff sits right next to hard evidence, the fluff is forgiven.

Info Density Power-words vs. Substance ratio.
15 Impact Weight: 30 / 100
50% Reputation

The information density is extremely low, characterized by a single 53-character sentence containing zero technical nouns, clinical protocols, or measurable outcomes. The specificity absence is scored at 5 points because the crawl contains zero instances of numbers, named clients, or frameworks. The body substance ratio is effectively 100 percent fluff/generic text since ‘This site is not accessible to users in your country’ carries no industry weight. No power words are used in headings as headings do not exist, resulting in a 0 for that sub-metric but a high penalty for the lack of any descriptive substance.

Information Density is read straight from the body copy: how much of the text carries grounded, checkable substance versus hollow filler. Below is the clean text the engine analyzed, then the industry’s known generic-claim patterns to weigh it against.

📝 The Narrative — clean text per page (the substance-vs-filler signal)
HOMEPAGE · THIN (https://keytruda.com) Forbidden
This site is not accessible to users in your country.
53 chars
🧭 Industry Context — common generic-claim patterns in Medical Devices, Pharma & Biotech to weigh the text against
Generic Claims: advancing human health, breakthrough innovation, life-changing therapies, transforming patient outcomes, pioneering medical science, the future of medicine…
Red Flags: FDA cleared used interchangeably with FDA approved, clinical claims without published study citations, breakthrough claims for incremental improvements, regulatory status implied but not specified, patient testimonials making efficacy claims, off-label promotion signals…
Semantic Drift Patterns: homepage claims breakthrough but pipeline page shows preclinical only, FDA approved claims but only for one indication, marketed broadly, claims clinical evidence but links to poster presentations not published studies, claims global reach but regulatory approvals are single-market…
Proof Expectations: specific regulatory clearance numbers (FDA 510(k), CE, TGA), published clinical trial results with ClinicalTrials.gov registration, ISO 13485 and GMP certification details, peer-reviewed publication citations, specific patent numbers and status, pharmacovigilance and adverse event reporting mechanisms…